[Purpose] To investigate the effects of Phase II cardiac exercise therapy (CET) on exercise capacity and changes in coronary risk factors (CRFs) of @entity1 with @entity583 ( @entity583 ). [Subjects] Thirty male subjects with @entity583 were divided into an experimental group (EG) and a control group (CG). Another 30 age-matched subjects with patent coronary arteries served as a normal-control group (NCG). [Methods] Subjects in EG (n=20) trained using a stationary bicycle for 30   min at their target heart rate twice a week for 8 weeks. Exercise capacity was defined as the maximal @entity209 ( @entity209 ) that subjects reached during the symptom-limited maximal exercise test. HR, BP and RPP were recorded. Subjects in EG and CG received exercise tests and screening for CRFs at the beginning of, end of, and 3 months after Phase II CET, while subjects in NCG participated only in the 1st test. [Results] @entity209 of CG did not improve until the 3rd test, while RPP at the 2nd test showed a significant increase. However, EG showed increased @entity209 at the 2nd test without increase of RPP, and increased their high density lipoprotein @entity165 (HDL-C) during the follow-up period between the 2nd and 3rd tests. [Conclusion] Phase II CET shortens the recovery time of exercise capacity, helps to maintain the gained exercise capacity and increases HDL-C in phase III.

Supervised Phase II Cardiac Exercise Therapy Shortens the Recovery of Exercise Capacity in XXXX with Acute @entity583 .

@entity1 :: ('9606', 'Species') :: ['patients'] @entity583 :: ('MESH:D009203', 'Disease') :: ['AMI', 'acute myocardial infarction'] @entity165 :: ('MESH:D002784', 'Chemical') :: ['cholesterol'] @entity209 :: ('MESH:D008659', 'Disease') :: ['metabolic equivalents', 'METs']
@entity1 :: (9606,Species) :: ['Patients']
